Skip to main content

Specialty Menu Navigation

  • COVID-19

  • Clinical

  • Coronary

  • Structural

  • Endovascular

  • Heart Failure

  • Heart Rhythm

  • Imaging & Physiology

  • Policy & Practice

Top User Menu

  • CME
  • Register
  • Login
Advertisement

Main navigation

  • News
    • Conference News
    • Features
    • Opinion
  • Conferences
  • Slides
  • Specialties
    • COVID-19
    • Clinical
    • Coronary
    • Structural
    • Endovascular
    • Heart Failure
    • Heart Rhythm
    • Imaging & Physiology
    • Policy & Practice
  • Podcasts
    • Heart Sounds
    • Rox Heart Radio
    • TCTMD Talking Points
    • Taking It To Heart
    • Heart Valve Matters
  • Videos
    • All Videos
    • Interviews
    • Topical Discussions
    • On Record
    • Live Cases
    • Partner Content
  • Fellows Forum
  • CV Team Forum
  • Slides (179)
  • News (61)
Podcast
  • Conference News
  • Editor's Corner
  • Daily News
  • Off Script
  • (-) TCT (240)
  • ACS/AMI (76)
  • Coronary (53)
  • DES/BRS/DCB (21)
  • Cath Lab (19)
  • Clinical Cardiology (18)
  • Clinical Pharma (16)
  • Policy & Practice (13)
  • Prevention (11)
  • Imaging & Physiology (9)
  • Lipids (9)
  • Angiography/QCA (6)
  • Cardiac Surgery (6)
  • Guidelines (4)
  • CTO (3)
  • Hemodynamic Support (3)
  • Structural Heart (3)
  • Diabetes (2)
  • Endovascular (2)
  • Heart Failure (2)
  • Heart Rhythm (2)
  • IVUS/NIRS (2)
  • Left Atrial Appendage (2)
  • OCT (2)
  • Plaque Modification (2)
  • Quality (2)
  • Training (2)
  • Vascular Access/Closure (2)
  • Women's Heart (2)
  • Aortic (1)
  • Aortic Valve (1)
  • Atrial Fibrillation (1)
  • Congenital (1)
  • CT/CT-FFR (1)
  • FFR (1)
  • Heart Rhythm Pharma (1)
  • Mitral Valve (1)
  • PFO/ASD (1)
  • Public Health (1)
  • Tricuspid Valve (1)
  • (-) CAD Pharma (240)
  • 2024 (1)
  • 2023 (3)
  • 2022 (3)
  • 2021 (10)
  • 2020 (9)
  • 2019 (10)
  • 2018 (7)
  • 2017 (3)
  • 2016 (192)
Displaying 201 - 220 of 240
Sort: Relevancy | Date
TCT-51. Comparison of Clopidogrel and Prasugrel in Patients with Unprotected Left main Disease Treated with Everolimus-eluting Stents: Insight from the Florence Left Main-PCI...
Presentation TCT 2012

TCT-51. Comparison of Clopidogrel and Prasugrel in Patients with Unprotected Left main Disease Treated with Everolimus-eluting Stents: Insight from the Florence Left Main-PCI...

Presenter: Renato Valenti
October 23, 2012
TCT-50. Influence of Age on Clinical Outcomes in Patients with NSTEMI Undergoing Treatment with Abciximab plus Unfractionated Heparin vs. Bivalirudin: Analysis of the ISAR...
Presentation TCT 2012

TCT-50. Influence of Age on Clinical Outcomes in Patients with NSTEMI Undergoing Treatment with Abciximab plus Unfractionated Heparin vs. Bivalirudin: Analysis of the ISAR...

Presenter: Lamin King
October 23, 2012
TCT-49. A Comparison of 5 mg Prasugrel with 75 mg Clopidogrel in Very Elderly Coronary Artery Disease Patients: Pharmacodynamics and Rates of High on-Treatment Reactivity
Presentation TCT 2012

TCT-49. A Comparison of 5 mg Prasugrel with 75 mg Clopidogrel in Very Elderly Coronary Artery Disease Patients: Pharmacodynamics and Rates of High on-Treatment Reactivity

Presenter: Joseph Jakubowski
October 23, 2012
Rationale and Data for Different DAPT Durations: From 3 to 30 Months (or Longer)
Presentation TCT 2012

Rationale and Data for Different DAPT Durations: From 3 to 30 Months (or Longer)

Presenter: David Kandzari
October 22, 2012
PARIS 1-Year: Impact of DAPT Cessation and Non-adherence on Adverse Events Following PCI
Presentation TCT 2012

PARIS 1-Year: Impact of DAPT Cessation and Non-adherence on Adverse Events Following PCI

Presenter: Roxana Mehran
October 22, 2012
PARADOX: A Prospective, Randomized Trial of Clopidogrel and Prasugrel in Smokers and Non-Smokers
Presentation TCT 2012

PARADOX: A Prospective, Randomized Trial of Clopidogrel and Prasugrel in Smokers and Non-Smokers

Presenter: Paul Gurbel
October 22, 2012
ISAR-SAFE Update
Presentation TCT 2012

ISAR-SAFE Update

Presenter: Adnan Kastrati
October 22, 2012
Do Patient and Stent Platform Specific Variables Matter (e.g. ACS vs. Stable CAD, First vs. Second Generation DES)?
Presentation TCT 2012

Do Patient and Stent Platform Specific Variables Matter (e.g. ACS vs. Stable CAD, First vs. Second Generation DES)?

Presenter: Elvin Kedhi
October 22, 2012
DAPT Trial Update
Presentation TCT 2012

DAPT Trial Update

Presenter: Laura Mauri
October 22, 2012
A Prospective, Randomized Trial of Tailored Clopidogrel Therapy vs. Prasugrel in Patients with High On-Treatment Platelet Reactivity
Presentation TCT 2012

A Prospective, Randomized Trial of Tailored Clopidogrel Therapy vs. Prasugrel in Patients with High On-Treatment Platelet Reactivity

Presenter: Laurent Bonello
October 22, 2012
A Prospective, Randomized Trial of Rosuvastatin Loading Prior to PCI
Presentation TCT 2012

A Prospective, Randomized Trial of Rosuvastatin Loading Prior to PCI

Presenter: Josef Veselka
October 22, 2012
A Preview to OPTIMIZE
Presentation TCT 2012

A Preview to OPTIMIZE

Presenter: Fausto Feres
October 22, 2012
Ticagrelor Enhances Adenosine-induced Coronary Vasodilatory Responses in Humans—a Randomised, Double-Blind, Placebo-Controlled, Crossover, Single Centre Study Using...
Presentation TCT 2012

Ticagrelor Enhances Adenosine-induced Coronary Vasodilatory Responses in Humans—a Randomised, Double-Blind, Placebo-Controlled, Crossover, Single Centre Study Using...

Presenter: Li-Ming Gan, Ann Wittfeldt, H?kan Emanuelsson, Sven Nylander, Magnus Andersson
January 03, 2012
The Effect Of Cilostazol On The Antiplatelet Efficacy Of Patients with Moderate Renal Dysfunction: Post-hoc Analysis Of CILON-T (Influence of CILostazol based triple...
Presentation TCT 2012

The Effect Of Cilostazol On The Antiplatelet Efficacy Of Patients with Moderate Renal Dysfunction: Post-hoc Analysis Of CILON-T (Influence of CILostazol based triple...

Presenter: Min-Ho Lee, Jung-Won Suh, Seung-Pyo Lee, Kyung Woo Park, Hae-Young Lee, Hyun-Jae Kang, Bon-Kwon Koo, Young-Seok Cho, Tae-Jin Youn, In-Ho Chae, Dong-Ju Choi, Seung-Woon Rha, Jang-Ho Bae, Taek-Geun Kwon, Jang-Whan Bae, Myeong-Chan Cho, Hyo-Soo Kim
January 03, 2012
The Controlled Reperfusion with Bivalirudin and Intra Coronary Abciximab in the  Porcine Mycoardial Infarction/Reperfusion Model
Presentation TCT 2012

The Controlled Reperfusion with Bivalirudin and Intra Coronary Abciximab in the Porcine Mycoardial Infarction/Reperfusion Model

Presenter: Piotr P. Buszman, Wojciech Wojakowski, Krzystof Milewski, Marcin Debinski, Jacek Pajak, Wanda Jackiewicz, Michal Jelonek, Pawel E. Buszman
January 03, 2012
Stopping Clopidogrel 1 year After Drug-Eluting Stent (DES) Implantation: Is It Safe?
Presentation TCT 2012

Stopping Clopidogrel 1 year After Drug-Eluting Stent (DES) Implantation: Is It Safe?

Presenter: Nalyaka Sambu, Hazel Dent, Timothy Warner, Nicola Englyst, Philip Leadbeater, Alex Hobson, Alison Calver, Simon Corbett, Huon Gray, Iain Simpson, John Morgan, Nick Curzen
January 03, 2012
Safety and Efficacy for the Use of Prasugrel in Patients Undergoing Percutaneous Coronary Intervention and Anticoagulated with Bivalirudin.
Presentation TCT 2012

Safety and Efficacy for the Use of Prasugrel in Patients Undergoing Percutaneous Coronary Intervention and Anticoagulated with Bivalirudin.

Presenter: Ana Laynez, Rebecca Torguson, Camille Hauville, Gabriel Sardi, Itsik Ben-Dor, Gabriel Maluenda, Michael A. Gaglia, Manuel A. Gonzalez, Israel M. Barbash, Zhenyi Xue, William O. Suddath, Lowell F. Satler, Kenneth M. Kent, Augusto D. Pichard, Ron Waksman
January 03, 2012
Response to Prasugrel in ST Elevation Myocardial Infarction Patients:  is it as Rapid as we Expected?
Presentation TCT 2012

Response to Prasugrel in ST Elevation Myocardial Infarction Patients: is it as Rapid as we Expected?

Presenter: Fr?d?ric Casassus, Lionel Leroux, Chloe James, Sali Sidibe, Agnalys Desplantes, David Naibo, Benjamin Seguy, Pierre Chevallereau, Pierre Coste
January 03, 2012
Protease Activated Receptor-1 (PAR-1) Mediated Platelet Aggregation is Dependant on Clopidogrel Response
Presentation TCT 2012

Protease Activated Receptor-1 (PAR-1) Mediated Platelet Aggregation is Dependant on Clopidogrel Response

Presenter: Rolf P. Kreutz, David A. Flockhart, Yvonne Kreutz, Jeffrey A. Breall
January 03, 2012
Prolonged Bivalirudin Infusion is Associated with Enhanced ST Segment Resolution Following Primary Percutaneous Coronary Intervention
Presentation TCT 2012

Prolonged Bivalirudin Infusion is Associated with Enhanced ST Segment Resolution Following Primary Percutaneous Coronary Intervention

Presenter: Bernardo Cortese, Ugo Limbruno, Sara De Matteis, Livia Diehl, Antonino Pit?
January 03, 2012

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • Current page 11
  • Page 12
  • Next page ››
  • Last page Last »
Advertisement
Become a Member

Register for TCTMD ®

Membership Plans
Sign Up for Our Newsletter

Receive the the latest news, research, and presentations from major meetings right to your inbox.

TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting the next wave of innovation in research and education that will help doctors save and improve the quality of their patients’ lives. For more information, visit http://www.crf.org.

Main Navigation

  • News
  • Conferences
  • Slides
  • Videos
  • Podcasts
  • Fellows Forum
  • CV Team Forum
  • CME

Specialty Menu Navigation

  • COVID-19

  • Clinical

  • Coronary

  • Structural

  • Endovascular

  • Heart Failure

  • Heart Rhythm

  • Imaging & Physiology

  • Policy & Practice

Footer

  • Advertising & Sponsorships
  • About TCTMD ®
  • FAQs
  • Editorial Policy
  • Contact Us
  • About CRF ®
Digital Health Awards Winner - Spring 2017 eHealthcare Leadership Awards - 2018 Winner HON Code Certified
Copyright © 2025. TCTMD ® All rights reserved.
  • Privacy Policy
  • Terms of Use
Created by Constructive
Sign In

New at TCTMD? Register today!

Forgot Password

Forgot Your Password?

Enter the email you used to register to reset your password.

Search TCTMD
cme
CME TITLE
Sign up for our newsletter

Sign up to receive the most important cardiovascular news, research, and major meeting presentations.

Address
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Main navigation

  • News
    • Conference News
    • Features
    • Opinion
  • Conferences
  • Slides
  • Specialties
    • COVID-19
    • Clinical
    • Coronary
    • Structural
    • Endovascular
    • Heart Failure
    • Heart Rhythm
    • Imaging & Physiology
    • Policy & Practice
  • Podcasts
    • Heart Sounds
    • Rox Heart Radio
    • TCTMD Talking Points
    • Taking It To Heart
    • Heart Valve Matters
  • Videos
    • All Videos
    • Interviews
    • Topical Discussions
    • On Record
    • Live Cases
    • Partner Content
  • Fellows Forum
  • CV Team Forum

Top User Menu

  • CME
  • Register
  • Login

Search TCTMD

Submit an Event
< >

Become a PREMIUM MEMBER or LOG IN to view exclusive content

This content is available for meeting attendees and/or Platinum Members

REGISTER for free or LOG IN to view this content

Now Playing